December 10, 2018

Selecting a Specialty Data Aggregator: Best Practices

By John Giannouris
Published Online: Monday, Nov 27, 2017

  • Timeliness: Are data provided according to the agreed-upon schedule? Are corrections provided in a timely manner?
  • Accuracy: Do data elements comply with business rules and reconcile with other data sources?
  • Completeness: Are all required fields populated to support data agreements and negotiated key performance indicators?
Data aggregators must be able to process data as soon as it is available rather than batching data to be processed. This makes the results of the quality control process almost immediately available, so both manufacturers and specialty providers can be alerted when data are not reported according to the contract. Standard operating procedures should be established to clarify what is expected of the specialty provider, the aggregator, and the manufacturer when an issue occurs. The aggregator then manages the entire process—as well as relationships with specialty providers—following the defined, detailed resolution and escalation process to resolve any issues as efficiently as possible.

Be sure to ask the aggregator for a specialty pharmacy network “scorecard,” an ideal tool to measure performance. The scorecard allows for quick assessment of an organization’s quality metrics and the ability to further investigate outliers or trend breaks for rapid resolution and improvement. Also consider the data aggregator’s ability to provide trending for patient metrics such as dispensed quantity and patient status aging, as well as reconciliation of products’ sales volume against dispensing activity. This form of granular data provides a detailed view into product placement and helps ensure the product reaches the patients who need it.

ValueCentric’s extensive experience with electronic interchange distribution data provides a framework to monitor product movement from the distribution center or third-party logistics provider all the way through the dispensed prescription via an all-in-one reporting and analytics platform. Coupled with the proprietary scorecard, this gives clients access to a complete view of data quality and product performance in a single platform.

As a result of progress milestones legislated by the Drug Supply Chain Security Act, serialization and lot number reporting will become the new standard. The market will demand that multiple stakeholders be able to track individual products down to the pharmacy level. Imagine the power of these data at your fingertips: With visibility into lot numbers and expiration, the challenges of returns accrual and recall management will be a thing of the past. The data aggregator should be prepared for this imminent and consequential change in the data paradigm looming just around the corner. 

An Evolving Market and Expanding Portfolios

About the Specialty Pharmacy Times Industry Guide

The Specialty Pharmacy Times Industry Guide includes comprehensive editorial content relative to all specialty pharmacy stakeholders. Content includes information relative to market trends, commercialization, distribution, order to cash, HUB Services, managed care strategies and DIR fees. The guide also includes profiles, and a complete list of stakeholders along the patient journey: specialty pharmacies, wholesaler distributors, manufacturers, support services, group purchasing, and trade associations.

Sign Up for the Industry Guide Newsletter

Copyright © 2006-2018 Pharmacy & Healthcare Communications, LLC
All Rights Reserved

About Us